AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 5 analysts
Fundamentals
Fundamentals institutional score is 87 using growth durability 86.7.
Valuation
Valuation institutional score is 54 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 80 using mean target upside 9.7%; dispersion penalty 5.2; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 22 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 2 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals and analyst consensus provide support, while valuation and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 28.6% above historical median. Valuation is declining — currently in the strongly overvalued zone (z-score: +1.56). Confidence: 78%.
Live forward EPS implies next-12-month EPS of ₹12.43. Applying the stock's normalized valuation corridor produces a fair range of ₹993.41 to ₹1,479.42, with base value near ₹1,321.81 (+321.9% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹12.43
Forward P/E
25.2x
Base Fair Value
₹1,321.81
Fair Range
₹993.41 - ₹1,479.42
Upside To Base
+321.9%
Estimate Source
Live forward EPS
Growth Estimate
+46.7%
5Y Average
74.19
Current
136.81
Overvalued
119.02
Undervalued
79.92
5Y Average
14.39
Current
26.53
Overvalued
21.67
Undervalued
5.87
5Y Average
—
Current
5.31
Overvalued
6.10
Undervalued
4.51
Peers & Comparison
Sector: Industrials · Theme: Business Support Services
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
KFIN TECHNOLOGIES LIMITED KFINTECHBusiness Support Services | +30.1% | 24.4% | 47.9x Premium | +25% vs avg | -14.5% |
INDEGENE LIMITED INDGNBusiness Support Services | +39.7% | 10.5% | 34.2x Fair | -11% vs avg | -1.0% |
RITES LIMITED RITESBusiness Support Services | +8.7% | 17.0% | 26.2x Undervalued | -32% vs avg | -6.5% |
SIS LIMITED SISBusiness Support Services | +29.7% | 0.9% | 45.3x Premium | +18% vs avg | +17.4% |
ARTEMIS MED SERVICE LTD trades at a premium (136.8x vs peer avg 38.4x), implying higher growth or quality expectations from the Business Support Services cohort. Peers include KFIN TECHNOLOGIES LIMITED, INDEGENE LIMITED, RITES LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹282 CrJun 2026Latest net profit
₹31 CrJun 2026Latest EPS
₹1.96Jun 2026Net margin
20.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 201 | 217 | 210 | 217 | 217 | 235 | 227 | 235 | 250 | 270 | 267 | 274 | 282 |
| Expenses + | 174 | 184 | 179 | 181 | 181 | 193 | 190 | 199 | 209 | 220 | 223 | 224 | 227 |
| Operating Profit | 27 | 33 | 32 | 36 | 36 | 42 | 37 | 36 | 41 | 50 | 44 | 50 | 55 |
| OPM % | 14% | 15% | 15% | 17% | 16% | 18% | 16% | 15% | 16% | 19% | 16% | 18% | 20% |
| Other Income + | 1 | 2 | 2 | 2 | 4 | 8 | 9 | 12 | 7 | 8 | 4 | 8 | 5 |
| Interest | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 |
| Depreciation | 9 | 9 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | 12 | 12 |
| Profit before tax | 13 | 19 | 16 | 19 | 22 | 31 | 27 | 29 | 30 | 40 | 30 | 39 | 42 |
| Tax % | 26% | 27% | 29% | 28% | 24% | 27% | 23% | 20% | 29% | 25% | 24% | 25% | 26% |
| Net Profit + | 10 | 14 | 12 | 14 | 17 | 23 | 21 | 23 | 21 | 30 | 23 | 30 | 31 |
| EPS in Rs | 0.73 | 1.01 | 0.85 | 1.02 | 1.24 | 1.64 | 1.51 | 1.69 | 1.54 | 2.16 | 1.42 | 1.87 | 1.96 |
| Raw PDF | |||||||||||||
| YOY Sales Growth % | 23.07% | 18.89% | 15.91% | 15.95% | 7.80% | 8.19% | 7.91% | 8.27% | 15.17% | 14.96% | 17.73% | 16.61% | 12.89% |
| Employee Cost % | 16.22% | 15.14% | 15.87% | 16.03% | 15.98% | 14.79% | 16.02% | 16.18% | 14.94% | 14.18% | 15.84% | 16.06% | 14.81% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.07 | 0.00 | 0.00 |
| Other income normal | 1.23 | 2.48 | 1.71 | 1.87 | 4.38 | 7.50 | 8.80 | 12.23 | 6.96 | 7.78 | 7.49 | 7.68 | 5.40 |
| Exceptional items AT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.34 | 0.00 | 0.00 |
| Profit excl Excep | 9.94 | 13.77 | 11.51 | 13.92 | 16.92 | 22.56 | 20.78 | 23.20 | 21.42 | 29.96 | 24.85 | 29.55 | 31.05 |
| Profit for PE | 9.94 | 13.77 | 11.51 | 13.92 | 16.92 | 22.56 | 20.78 | 23.20 | 21.42 | 29.96 | 24.85 | 29.55 | 31.05 |
| Profit for EPS | 9.94 | 13.77 | 11.51 | 13.92 | 16.92 | 22.56 | 20.78 | 23.20 | 21.42 | 29.96 | 22.51 | 29.55 | 31.05 |
| YOY Profit Growth % | 14.25% | 40.51% | 6.67% | 33.85% | 70.22% | 63.83% | 80.54% | 66.67% | 26.60% | 32.80% | 19.59% | 27.37% | 44.96% |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome